Serum activin-A as a predictive and prognostic marker in critically ill patients with sepsis (Q39926432)

15 September 2017

Serum activin-A as a predictive and prognostic marker in critically ill patients with sepsis (English)

1 reference

15 September 2017

0 references

8

Young Whan Kim

1 reference

15 September 2017

Jung-Kyu Lee

1

1 reference

15 September 2017

Sun Mi Choi

2

1 reference

15 September 2017

Jinwoo Lee

3

1 reference

15 September 2017

Young Sik Park

4

1 reference

15 September 2017

Chang Hoon Lee

5

1 reference

15 September 2017

Jae-Joon Yim

6

1 reference

15 September 2017

Chul-Gyu Yoo

7

1 reference

15 September 2017

Sung Koo Han

9

1 reference

15 September 2017

Sang-Min Lee

10

1 reference

15 September 2017

10 March 2016

1 reference

15 September 2017

1 reference

15 September 2017

21

1 reference

15 September 2017

5

1 reference

15 September 2017

891-897

1 reference

The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study

15 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12751

Severe sepsis and septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12751

Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12751

APACHE II: a severity of disease classification system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12751

Serial evaluation of the SOFA score to predict outcome in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12751

Diagnostic and prognostic value of presepsin in the management of sepsis in the emergency department: a multicenter prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12751

Presepsin (soluble CD14 subtype) and procalcitonin levels for mortality prediction in sepsis: data from the Albumin Italian Outcome Sepsis trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12751

Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12751

Pros and cons of using biomarkers versus clinical decisions in start and stop decisions for antibiotics in the critical care setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12751

The activins and their binding protein, follistatin-Diagnostic and therapeutic targets in inflammatory disease and fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12751

Activin-A: a novel dendritic cell-derived cytokine that potently attenuates CD40 ligand-specific cytokine and chemokine production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12751

New insights into TGF-beta-Smad signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12751

Activin A induces erythroid gene expressions and inhibits mitogenic cytokine-mediated K562 colony formation by activating p38 MAPK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12751

Role of activin-A in cigarette smoke-induced inflammation and COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12751

Activin and transforming growth factor-beta signaling pathways are activated after allergen challenge in mild asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12751

Activin-A overexpression in the murine lung causes pathology that simulates acute respiratory distress syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12751

Diagnostic applications for inhibin and activins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12751

Elevated levels of activin A in clinical and experimental pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12751

Identification of four novel serum protein biomarkers in sepsis patients encoded by target genes of sepsis-related miRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12751

Serum concentrations of activin and follistatin are elevated and run in parallel in patients with septicemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12751

2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12751

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12751

Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12751

Clinical and economic consequences of hospital-acquired resistant and multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12751

Characterisation of the rapid release of activin A following acute lipopolysaccharide challenge in the ewe.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12751

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12751

Activin as an anti-inflammatory cytokine produced by microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12751

Divergent cell-specific effects of activin-A on thymocyte proliferation stimulated by phytohemagglutinin, and interleukin 1beta or interleukin 6 in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12751

The sepsis seesaw: tilting toward immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12751

Activin A is a critical component of the inflammatory response, and its binding protein, follistatin, reduces mortality in endotoxemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12751

21 January 2018

Identifiers

DOI

10.1111/RESP.12751

1 reference

15 September 2017

1 reference